The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

O.V. Zaytseva

Helmholtz National Medical Research Center of Eye Diseases;
A.I. Evdokimov Moscow State University of Medicine and Dentistry

N.V. Neroeva

Helmholtz National Medical Research Center of Eye Diseases

T.D. Okhotsimskaya

Helmholtz National Medical Research Center of Eye Diseases

E.V. Bobykin

Ural State Medical University

Current view on the issue of insufficient effectiveness of anti-VEGF therapy for age-related macular degeneration

Authors:

O.V. Zaytseva, N.V. Neroeva, T.D. Okhotsimskaya, E.V. Bobykin

More about the authors

Journal: Russian Annals of Ophthalmology. 2022;138(1): 90‑99

Views: 778

Downloaded: 31


To cite this article:

Zaytseva OV, Neroeva NV, Okhotsimskaya TD, Bobykin EV. Current view on the issue of insufficient effectiveness of anti-VEGF therapy for age-related macular degeneration. Russian Annals of Ophthalmology. 2022;138(1):90‑99. (In Russ.)
https://doi.org/10.17116/oftalma202213801190

Recommended articles:
Fari­cimab: from research to clinical practice. Russian Annals of Ophthalmology. 2023;(4):115-120
Choroidal neovascularization in central serous chorioretinopathy. Russian Annals of Ophthalmology. 2023;(6):152-157

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.